Neuraxis宣佈向FDA提交了新的資料，以擴展其Ib-Stim標籤；遵守紐交所有關審計

快訊 · 06/07 21:00

Neuraxis Announces New Submission to the FDA for the Expansion of Its Ib-Stim Label; Provides Compliance With NYSE Guidelines on Audit Disclosure

Neuraxis宣佈向FDA提交了新的資料，以擴展其Ib-Stim標籤；遵守紐交所有關審計披露的指引。